CompletedNot Applicable

NMES Effects on Substrate Metabolism and IGF-1

Turkey (Türkiye)24 participantsStarted 2017-03-17

Plain-language summary

The aim of this study is to investigate whether neuromuscular electrostimulation (NMES) training coupled with high-intensity interval training (HIIT) and moderate intensity continuous aerobic training has an effect on the metabolic, cardiovascular and hormonal components compared to respective training protocols without concurrent NMES as a exercise performance enhancement strategy.

Who can participate

Age range

18 Years – 30 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- All participants were healthy with no musculoskeletal injuries and had not participated in lower-body resistance training for six months prior to the study. Exclusion Criteria: * Individuals with musculoskeletal injuries and had participated in lower-body resistance training for six months prior to the study has been excluded from the enrollement for the current study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Body composition via Bioelectrical Impedance Analysis (Tanita 418-MA, Japan)

Timeframe: From enrollment to the end of treatment at 8 weeks

Height (cm) via a stadiometer (Holtain Ltd., UK).

Timeframe: From enrollment to the end of treatment at 8 weeks

Heart rate (bpm) via 12-lead ECG

Timeframe: From enrollment to the end of treatment at 8 weeks

Blood Lactate Concentration (mmol/L) via Lactate Pro 2 analyzer

Timeframe: From enrollment to the end of treatment at 8 weeks

SERUM INSULIN-LIKE GROWTH FACTOR-1 (IGF-1 ng/mL)

Timeframe: From enrollment to the end of treatment at 8 weeks

VO2 - Volume of oxygen (ml/kg/min) VCO2 - Volume of carbon dioxide (ml/kg/min)

Timeframe: From enrollment to the end of treatment at 8 weeks

Energy expenditure (L/min) via indirect calorimetry (CareFusion MasterScreen CPX).

Trial details

NCT IDNCT06850532

SponsorMersin University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-02-13

View on ClinicalTrials.gov More The Effects of Neuromuscular Electrical Stimulation on Exercise Performance trials

Plain-language summary

Who can participate

Age range

18 Years – 30 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Body composition via Bioelectrical Impedance Analysis (Tanita 418-MA, Japan)

Timeframe: From enrollment to the end of treatment at 8 weeks

Height (cm) via a stadiometer (Holtain Ltd., UK).

Timeframe: From enrollment to the end of treatment at 8 weeks

Heart rate (bpm) via 12-lead ECG

Timeframe: From enrollment to the end of treatment at 8 weeks

Blood Lactate Concentration (mmol/L) via Lactate Pro 2 analyzer

Timeframe: From enrollment to the end of treatment at 8 weeks

SERUM INSULIN-LIKE GROWTH FACTOR-1 (IGF-1 ng/mL)

Timeframe: From enrollment to the end of treatment at 8 weeks

VO2 - Volume of oxygen (ml/kg/min) VCO2 - Volume of carbon dioxide (ml/kg/min)

Timeframe: From enrollment to the end of treatment at 8 weeks

Energy expenditure (L/min) via indirect calorimetry (CareFusion MasterScreen CPX).